Research from Adelaide University indicates that daily probiotic supplementation could improve gut and skin health in dogs, potentially reducing skin infections.
Recent advancements in protein engineering may improve cancer therapies. Proteases, enzymes that act as molecular scissors, are crucial in developing treatments that target both viral replication and cancer cell destruction.
A closer look at the ongoing disputes surrounding drug price transparency and the role of pharmacy benefit managers (PBMs) in this contentious issue.
Recent developments highlight significant progress in targeting KRAS, a key player in cancer treatment, alongside other notable biotech news including the Breakthrough Prize winners.
In recent pharmaceutical news, Trump has shown support for psychedelic treatment options while discussions continue regarding the future of weight-loss drugs.
Recent discussions highlight the effects of cannabis on adolescent brain development, alongside updates on the CDC director nominee and a measles outbreak.
Recent findings suggest that prolonged use of a drug from Nektar Therapeutics may encourage hair growth in individuals suffering from alopecia.
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
The American Association of Cancer Researchers' annual meeting showcases significant advancements in the development of KRAS-targeting therapies, particularly by Revolution Medicines.
Early retirement at 62 can be appealing, but it comes with significant financial considerations, including a $47,000 healthcare gap before Medicare starts.
Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.
The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.
Despite a notable increase in Medicare Advantage spending in Puerto Rico, the expected improvements in plan quality have not materialized.
The latest issue of Health Affairs delves into critical topics such as drug pricing strategies, the role of behavioral health, and hospital policies.
The first year of the ACO program aimed at enhancing equity and community health has shown promising results, according to Health Affairs.
A recent analysis explores how changing patient cost-sharing practices are affecting the financial stability of both urban and rural hospitals.
A recent study highlights a notable decline in hospital utilization in Maryland, showing an 11 percentage point decrease compared to other states from 2013 to 2023.
A recent analysis highlights the trends in national spending on mental health and substance use disorder treatment from 2000 to 2021, reflecting case growth over the years.
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
In a recent directive, Trump has called on federal agencies to expedite access to psychedelic treatments and reconsider their classification as controlled substances.